Schedule 13G ownership disclosure

DECIPHERA PHARMACEUTICALS IN

Security class unavailable · CUSIP: 24344T101

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-19-000431
Form type
SC 13G
Filer
Deciphera Pharmaceuticals, Inc.
CIK
CIK 1654151
Filed
Feb 13, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub